The Recall Desk
ModerateFDA (Devices)·Z-1977-2023·Announced 2023-06-28

FDA Recalls MiSeq Dx Instruments for Software Cybersecurity Vulnerability

Illumina recalls 740 MiSeq Dx sequencing instruments due to a software cybersecurity vulnerability affecting the Universal Copy Service component. No patient harm reported.

What this means for you

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: This FDA Class II recall involves only a theoretical cybersecurity vulnerability with no reported illnesses, injuries, or confirmed exploitation. The recall appears precautionary in nature.

Plain-English summary

Illumina, Inc. is recalling 740 units of the MiSeq Dx Instrument (Catalog No. M70101) due to a cybersecurity vulnerability in the Universal Copy Service (UCS) software. The affected software versions include UCS 2.5.0.

The recalled instruments have worldwide distribution, including across the United States and to more than 40 countries including Canada, the United Kingdom, Germany, Japan, Australia, and others listed in the FDA recall notice.

No illnesses, injuries, or confirmed incidents related to this vulnerability have been reported to date. The FDA classified this as a Class II recall.

The recalled product

Product
MiSeq Dx Instrument, Catalog # M70101, containing Universal Copy Service (UCS) software.
Manufacturer
Illumina, Inc.
Hazard
  • cybersecurity-vulnerability

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

  • UCS Versions: UCS 2.5.0/ UDI-DI: (00)816270020002

Distribution

Distributed nationwide across the United States.